- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Brain+ A/S: Update on in-court restructuring proceedings - 4 February 2026 | 125 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT No. 2026-5
BRAIN+ A/S - Investor News
Copenhagen, Denmark, 4 February 2026, Brain+ A/S (Nasdaq First North: BRAINP)
Copenhagen, Denmark, 4 February 2026 Brain+ A/S (the "Company")... ► Artikel lesen | |
| 20.01. | Brain+ A/S: Notice of in-court restructuring proceedings of BRAIN+ A/S | 69 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT No. 2026-2
Brain+ A/S - Inside information
Copenhagen, Denmark, 20 January 2026, Brain+ A/S (Nasdaq First North: BRAINP)
Copenhagen, Denmark, 20 January 2026 - BRAIN+ A/S (the "Company")... ► Artikel lesen | |
| 20.01. | Brain+ A/S: Brain+ is seeking restructuring proceedings | 167 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT NO. 2026-1
Copenhagen, Denmark, 20 January 2026, Brain+ A/S (Nasdaq First North: BRAINP)
As previously announced on 19 November 2025, Brain+ A/S has been exploring various options... ► Artikel lesen | |
| 08.01. | Brain+ A/S: Brain+ Investor Update - December 2025 | 81 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 8 January 2026, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S reports continued international expansion alongside strengthened traction in its home market of Denmark... ► Artikel lesen | |
| BRAIN+ A/S Aktie jetzt für 0€ handeln | |||||
| 04.12.25 | Brain+ A/S: Brain+ Investor Update - November | 125 | GlobeNewswire (Europe) | NEWS RELEASE
Brain+ Investor Update - November
Copenhagen, Denmark, 4 December 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S reports continued commercial traction, national research recognition... ► Artikel lesen | |
| 19.11.25 | Brain+ A/S: Brain+ A/S updates its financial guidance for 2025 | 164 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT No. 2025-19
Copenhagen, Denmark, 19 November 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") updates its financial guidance for 2025 to reflect... ► Artikel lesen | |
| 06.11.25 | Brain+ A/S: Brain+ investor update - October | 133 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 6 November 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S reports continued commercial traction and operational expansion in its October investor update,... ► Artikel lesen | |
| 06.10.25 | Brain+ A/S: Brain+ appoints new Chief Financial Officer | 144 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT - No. 2025-18Copenhagen, Denmark, 6 October 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") has appointed Otto Rasmussen, an experienced financial... ► Artikel lesen | |
| 24.09.25 | Brain+ A/S: Brain+ launches first Ayla NHS pilot with one of the UK's largest primary care practices | 147 | GlobeNewswire (Europe) | NEWS RELEASECopenhagen, Denmark, 24 September 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") has signed an agreement with a large primary care practice in the South... ► Artikel lesen | |
| 16.09.25 | Brain+ A/S: Brain+ signs agreement with Agincare Homes - the fourth UK care home group to deploy effective dementia therapy with Ayla | 245 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, September 16, 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") has signed an agreement with Agincare Homes Holdings Ltd, UK ("Agincare")... ► Artikel lesen | |
| 15.09.25 | Brain+ A/S: The Chief Financial Officer to transition, replacement search has been initiated | 164 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT - No. 2025-17
Copenhagen, Denmark, September 15, 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") announces that its Chief Financial Officer... ► Artikel lesen | |
| 02.09.25 | Brain+ A/S: Brain+ expands its agreement with Southcare Homes Group to deploy Ayla across the group | 295 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 2 September 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") has signed an expanded contract with Southcare Homes Group ("Southcare")... ► Artikel lesen | |
| 28.08.25 | Brain+ A/S: Brain+ publishes Half Year Report for 2025 | 252 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT - No. 2025-16Copenhagen, Denmark, August 28, 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
In H1 2025, Brain+ A/S ("Brain+" or "the Company") realized a net result of DKK -8.0... ► Artikel lesen | |
| 05.06.25 | Brain+ A/S: Brain+ signs agreement with UK care home group Majesticare deploying Ayla for effective dementia care | 164 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 5 June 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") has signed a partnership with Majesticare, a leading UK care home provider... ► Artikel lesen | |
| 30.05.25 | Brain+ A/S: Brain+ A/S - Minutes of Annual General Meeting | 158 | GlobeNewswire (Europe) | Copenhagen, Denmark, 30 May 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Today at 08:00 CEST, the Annual General Meeting was held in Brain+ A/S, ("Brain+" or "the Company"). A total of 16.45 % of... ► Artikel lesen | |
| 05.05.25 | Brain+ A/S: Brain+ selected for the NHS Dementia Innovators Programme in the UK | 303 | GlobeNewswire (Europe) | Copenhagen, Denmark, 5 May 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") has been selected for the Dementia Innovators Programme in the United Kingdom (UK),... ► Artikel lesen | |
| 16.04.25 | Brain+ A/S: Brain+ appoints CCO Devika Wood as new CEO | 384 | GlobeNewswire (Europe) | Copenhagen, Denmark, 16 April 2025 - Brain+ A/S (Nasdaq First North: BRAINP)Brain+ A/S ("Brain+" or the "Company") announces that the Board has appointed the Company's Chief Commercial Officer (CCO)... ► Artikel lesen | |
| 02.04.25 | Brain+ A/S: Brain+ announces outcome of unit rights issue | 313 | GlobeNewswire (Europe) | Copenhagen, Denmark, 2 April 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA... ► Artikel lesen | |
| 19.03.25 | Brain+ A/S: Brain+ expands its UK sales pipeline to €+500,000 in revenue and reveals Key Performance Indicators | 222 | GlobeNewswire (Europe) | Copenhagen, Denmark, 19 March 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") today reports continued strong momentum in its sales pipeline, now exceeding €500... ► Artikel lesen | |
| 06.03.25 | Brain+ A/S: Brain+ resolves to carry out its earlier announced unit rights issue of up to approximately DKK 16 million | 394 | GlobeNewswire (Europe) | Copenhagen, Denmark, 6 March 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | HV-Termine: Hauptversammlungen bei Adv. Blockchain, Aurubis, Fortec, Schott, Siemens, Healthineers, Stabilus, TUI | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | Fresenius Medical Care: Ein Neuanfang nach turbulenten Zeiten? | ||
| FRESENIUS | 49,760 | +1,06 % | Fresenius: 2026 setzt sich das Wachstum fort | Am 25. Februar wird Fresenius Zahlen zum vierten Quartal publizieren. Die Analysten der DZ Bank rechnen mit einer soliden Entwicklung. Wachstumsinvestitionen bei Kabi dürften sich bei den Margen bemerkbar... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,990 | +2,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| GERRESHEIMER | 25,660 | +1,99 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 34,10 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Spezialverpackungshersteller... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,750 | +2,84 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| PROGYNY | 21,960 | +0,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,500 | +0,15 % | Frontalangriff: Hatte Novo das auf der Rechnung? Hims kontert mit billiger Pillen-Variante! | © Foto: DALL-EWährend die Aktien von Hims mit einem zweistelligen Plus in den Handelstag startet, muss Novo Nordisk erneut kräftig Federn lassen. Die US-Pharmaplattform startet den Verkauf einer deutlich... ► Artikel lesen | |
| UNITEDHEALTH | 232,15 | -0,77 % | Märkte am Morgen: Bitcoin rauscht ab - Gold, Silber, Strategy, Amazon, UnitedHealth, SAP, Bayer | Der DAX kommt weiter nicht in die Gänge. Gestern startete der Leitindex zwar ordentlich, rutschte dann aber deutlich ab. Immerhin reduzierte er seine Verluste kurz vor Handelsende etwas. Heute deuten... ► Artikel lesen | |
| RXSIGHT | 8,390 | +7,29 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer | ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |
BRAIN+ A/S gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRAIN+ A/S finden Sie auf Wallstreet Online.